Clinical trial
Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of…
NCT00282178 · Umeå University, Other · Completed
Key facts
| NCT number | NCT00282178 |
|---|---|
| Title | Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo |
| Official title | A 36 Week Three-Center Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo |
| Lead sponsor | Umeå University, Other |
| Collaborators | Sahlgrenska University Hospital AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension, Obesity |
| Intervention type | Drug |
| Interventions | Hydrochlorothiazide, Placebo, Candesartan |
| Enrollment | 26 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Jan 25, 2006 |
| Last update posted | Oct 16, 2008 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: